Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials

Thumbnail Image

Files

Journal Article.pdf (863.85 KB)

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

WILEY-BLACKWELL

Abstract

Description

Keywords

Citation

WOS

URI

https://hdl.handle.net/10539/41704

Collections

Academic Wits Research Outputs (All submissions)

Endorsement

Review

Supplemented By

Referenced By